Anu Anttonen

629 total citations
20 papers, 514 citations indexed

About

Anu Anttonen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Anu Anttonen has authored 20 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Anu Anttonen's work include Proteoglycans and glycosaminoglycans research (5 papers), Palliative Care and End-of-Life Issues (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Anu Anttonen is often cited by papers focused on Proteoglycans and glycosaminoglycans research (5 papers), Palliative Care and End-of-Life Issues (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Anu Anttonen collaborates with scholars based in Finland and United States. Anu Anttonen's co-authors include Heikki Joensuu, M Kajanti, Markku Jalkanen, Päivi Heikkilä, Pia Heikkilä, Petri Salvén, Sirpa Leppä, Minna Eriksson, Vuokko L. Kinnula and Henrik Alfthan and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Lung Cancer.

In The Last Decade

Anu Anttonen

16 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anu Anttonen Finland 8 342 253 135 124 66 20 514
Veli-Matti Kosma Finland 6 172 0.5× 112 0.4× 109 0.8× 79 0.6× 32 0.5× 8 411
Hemangini H. Vora India 13 228 0.7× 41 0.2× 260 1.9× 100 0.8× 50 0.8× 35 496
Riitta Mäkitaro Finland 13 229 0.7× 104 0.4× 214 1.6× 168 1.4× 204 3.1× 15 538
So-Young Yeo South Korea 9 280 0.8× 60 0.2× 259 1.9× 116 0.9× 58 0.9× 12 497
Fátima Solange Pasini Brazil 13 223 0.7× 25 0.1× 165 1.2× 157 1.3× 50 0.8× 31 444
Neelam G. Shah India 13 225 0.7× 36 0.1× 338 2.5× 102 0.8× 69 1.0× 23 591
N J Agnantis Greece 13 169 0.5× 34 0.1× 223 1.7× 87 0.7× 69 1.0× 24 429
R. Donnellan South Africa 7 302 0.9× 71 0.3× 308 2.3× 106 0.9× 92 1.4× 12 576
Renya Zhang China 11 162 0.5× 33 0.1× 92 0.7× 69 0.6× 84 1.3× 21 290
Lorian Menkema Netherlands 7 199 0.6× 36 0.1× 120 0.9× 140 1.1× 85 1.3× 7 366

Countries citing papers authored by Anu Anttonen

Since Specialization
Citations

This map shows the geographic impact of Anu Anttonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Anttonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Anttonen more than expected).

Fields of papers citing papers by Anu Anttonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anu Anttonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Anttonen. The network helps show where Anu Anttonen may publish in the future.

Co-authorship network of co-authors of Anu Anttonen

This figure shows the co-authorship network connecting the top 25 collaborators of Anu Anttonen. A scholar is included among the top collaborators of Anu Anttonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anu Anttonen. Anu Anttonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koivunoro, Hanna, Tiina Seppälä, Leena Kankaanranta, et al.. (2025). Predictive factors of oral mucositis in patients with locally recurrent inoperable head and neck cancer treated with boron neutron capture therapy. Acta Oncologica. 64. 1307–1311.
3.
Mali, Pekka, Anu Anttonen, Kaisa Lehtiö, et al.. (2025). Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020. Cancer Treatment and Research Communications. 45. 100996–100996. 1 indexed citations
4.
Kytölä, Soili, Erdoğan Pekcan Erkan, Maarit Ahtiainen, et al.. (2025). Performance Comparison of Droplet Digital PCR and Next‐Generation Sequencing for Circulating Tumor DNA Detection in Non‐Metastatic Rectal Cancer. Cancer Medicine. 14(9). e70943–e70943. 2 indexed citations
5.
Larjavaara, Suvi, et al.. (2024). Palliative radiotherapy of soft tissue tumoral masses based on diagnostic instead of planning computed tomography scans. Physics and Imaging in Radiation Oncology. 32. 100682–100682.
6.
7.
Kauppi, Juha, et al.. (2023). Chemoradiation for oesophageal cancer: the choice of treatment modality. Radiation Oncology. 18(1). 93–93. 2 indexed citations
8.
Leskelä, Riikka‐Leena, et al.. (2023). Effect of palliative care decisions making on hospital service use at end-of-life in patients with malignant brain tumors: a retrospective study. BMC Palliative Care. 22(1). 39–39. 7 indexed citations
9.
Koskenmies, Sari, et al.. (2023). Early clinical experience with a degraded 4 MeV electron beam in radiotherapy of superficial basal cell carcinoma. Physics and Imaging in Radiation Oncology. 27. 100487–100487.
10.
Larjavaara, Suvi, et al.. (2023). Palliative intensity modulated radiotherapy of bone metastases based on diagnostic instead of planning computed tomography scans. Physics and Imaging in Radiation Oncology. 27. 100456–100456. 3 indexed citations
11.
Porra, Liisa, L. Wendland, Tiina Seppälä, et al.. (2022). From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience. Cancer Biotherapy and Radiopharmaceuticals. 38(3). 184–191. 9 indexed citations
12.
Leskelä, Riikka‐Leena, et al.. (2022). Effect of Palliative Care Decision on Use of Hospital Services in Pancreatic Cancer Patients: A Retrospective Study. Anticancer Research. 42(11). 5457–5463. 2 indexed citations
13.
Anttonen, Anu, et al.. (2022). End-of-life care of patients with esophageal or gastric cancer: decision making and the goal of care. Acta Oncologica. 61(10). 1173–1178. 1 indexed citations
14.
Sihvo, Eero, Anu Anttonen, & Riikka Huuhtanen. (2014). [Treatment of esophageal cancer].. PubMed. 130(6). 565–72. 3 indexed citations
15.
Anttonen, Anu, Sirpa Leppä, Pia Heikkilä, Reidar Grénman, & Heikki Joensuu. (2006). Effect of treatment of larynx and hypopharynx carcinomas on serum syndecan-1 concentrations. Journal of Cancer Research and Clinical Oncology. 132(7). 451–457. 9 indexed citations
16.
17.
Joensuu, Heikki, Anu Anttonen, Minna Eriksson, et al.. (2002). Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.. PubMed. 62(18). 5210–7. 133 indexed citations
18.
Anttonen, Anu, Päivi Heikkilä, Mikael Kajanti, Markku Jalkanen, & Heikki Joensuu. (2001). High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer. 32(3). 297–305. 71 indexed citations
19.
Anttonen, Anu, M Kajanti, Päivi Heikkilä, Markku Jalkanen, & Heikki Joensuu. (1999). Syndecan-1 expression has prognostic significance in head and neck carcinoma. British Journal of Cancer. 79(3-4). 558–564. 116 indexed citations
20.
Salvén, Petri, Pia Heikkilä, Anu Anttonen, M Kajanti, & Heikki Joensuu. (1997). Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.. PubMed. 10(11). 1128–33. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veli-Matti Kosma Breakdown of academic impact, for papers by Hemangini H. Vora Breakdown of academic impact, for papers by Riitta Mäkitaro Breakdown of academic impact, for papers by So-Young Yeo Breakdown of academic impact, for papers by Fátima Solange Pasini Breakdown of academic impact, for papers by Neelam G. Shah Breakdown of academic impact, for papers by N J Agnantis Breakdown of academic impact, for papers by R. Donnellan Breakdown of academic impact, for papers by Renya Zhang Breakdown of academic impact, for papers by Lorian Menkema
Rankless by CCL
2026